Alcon Receives CE Mark Approval for Clareon Vivity Intraocular Lens
Alcon, a leading eye care company, has received CE Mark approval for its Clareon Vivity intraocular lens. This approval enables the product to be marketed and sold in Europe.
The Clareon Vivity intraocular lens is now available in Europe, expanding visual possibilities for patients.
Acquisition of LENSAR
Alcon has agreed to acquire LENSAR, a medical technology company. The acquisition aims to strengthen Alcon’s cataract equipment and technology portfolio.
Key highlights of the acquisition include:
- Improved efficiency of cataract surgery globally
- Enhanced capabilities in cataract equipment and technology
- Strengthened position in the eye care market